MarginsXMarginsX
Home › Markets › Health Care › MEDS

DataMeds AI Inc. (MEDS)

MEDS trades on Nasdaq in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6421
-13.68% on the day
Market cap
$3.1M
Nano cap
Revenue · 2025
$23.3M
+28.7% on 2024
Net income · 2025
-$101.3M
-433.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/2030763/000149315226012004/0001493152-26-012004-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMEDS on Nasdaq
SectorHealth Care
IndustryOther Pharmaceuticals
CountryUnited States
IPO year2025
SEC CIK0002030763
SEC industry codeWholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated inDE

Financials · 2025

LineValue
Revenue$23.3M
Net income-$101.3M
Operating income-$93.7M
Net margin-433.9%
Operating margin-401.7%
Revenue growth+28.7%
Cash$43K
Total assets$30.5M
P/E (computed)Net income was not positive
P/S (computed)0.1×

Warning signs

Cash runway
2.1 months
$2.5M cash at June 30, 2026
Share count, 1 year
+219.0%
2025-11-19 to 2026-11-13
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued."
10-Q 2026-11-13
Cash and burn$2.5M cash; operating cash flow -$3.4M a quarter.Report 2026-06-30
Shares outstanding5,724,857 (2026-11-13); 89,729,281 a year earlier. 1y figure adjusted for split (1-for-50 overall).Cover page 2026-11-13
Reverse splits, 3 years1; latest 1-for-50 on 2026-05-26Source 2026-05-26
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-04-15
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-04-21
AuditorSURI AND CO, Bengaluru, India; changed auditors 2 times in 24 months8-K 4.01 2025-11-17
Late filings, 12 months2 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$1.8M-$18.4M-$2.9M$2.5M$31.8M$8.0M10-Q 2026-08-17
Q1 2026
2026-03-31
$1.6M-$7.7M-$3.4M$52K$27.8M$14.0M10-Q 2026-05-19
Q4 2025
2025-12-31
$1.7M-$27.9M-$6.3M$43K$23.5M$23.3M10-K 2026-03-20
Q3 2025
2025-09-30
$3.0M-$34.3M-$1.1M$4.2M$24.8M$34.1M10-Q 2025-11-19
Q2 2025
2025-06-30
$7.8M-$6.7M-$2.1M$420K$23.3M$36.7M10-Q 2026-08-17
Q1 2025
2025-03-31
$10.9M-$32.4M-$1.3M$2.5M$24.1M$29.0M10-Q 2026-05-19
Q4 2024
2024-12-31
$12.4M-$4.3M-$2.6M$1.0M$23.4M$18.1M10-K 2026-03-20
Q3 2024
2024-09-30
$5.7M-$1.9M$1.0MNot filedNo debt tagsNeeds four quarters10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-11-16
Latest annual report10-K/A2026-04-24
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-16
Latest proxyPRE 14A2026-06-18

Source: SEC EDGAR submissions feed, 184 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-36.9%
1 month-75.4%
3 months-50.1%
Year to date-96.3%
1 year-97.3%
From 52-week high-97.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Other Pharmaceuticals

TickerCompanyPriceDayMarket cap
HKPDCellyan Biotechnology Co. Ltd$1.61-0.62%$4.0M
ESYNEnerSyn Global Inc.$1.250.00%$37.2M
ZSTKZeroStack Corp.$2.80-1.75%$61.1M
NUSNu Skin Enterprises Inc.$3.93-2.48%$191.3M
COSMCosmos Health Inc.$2.49-23.15%$250.6M
HLFHerbalife Ltd. Common Shares$16.15+1.19%$1.7B
CAHCardinal Health Inc.$283.85+0.98%$65.6B
CORCencora Inc.$356.94-0.58%$68.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier